biguanides has been researched along with Experimental Hepatoma in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin was also effective in significantly enhancing insulin binding in both IM-9 and MCF-7 cells." | 1.26 | Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells. ( Goldfine, ID; Pezzino, V; Vigneri, R; Wong, KY, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vigneri, R | 1 |
| Pezzino, V | 1 |
| Wong, KY | 1 |
| Goldfine, ID | 1 |
| De Vries, CP | 1 |
| van der Veen, EA | 1 |
2 other studies available for biguanides and Experimental Hepatoma
| Article | Year |
|---|---|
Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
Topics: Animals; Biguanides; Breast Neoplasms; Cell Line; Female; Fibroblasts; Humans; Insulin; Liver Neopla | 1982 |
Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
Topics: Animals; Biguanides; Cells, Cultured; Hypoglycemic Agents; Liver Neoplasms, Experimental; Rats; Rece | 1986 |